Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy

Coronavirus disease 2019 (COVID-19) is a globally communicable public health disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV-2). Eradication of COVID-19 appears practically impossible but, therefore, more effective pharmacotherapy is needed. The deteriorated clinical pres...

Descripción completa

Detalles Bibliográficos
Autor principal: Shibabaw, Tewodros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547786/
https://www.ncbi.nlm.nih.gov/pubmed/33116747
http://dx.doi.org/10.2147/JIR.S278335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547786/
https://www.ncbi.nlm.nih.gov/pubmed/33116747
http://dx.doi.org/10.2147/JIR.S278335

Ejemplares similares